Los Angeles Capital Management LLC reduced its position in Xylem Inc. (NYSE:XYL – Free Report) by 42.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 435,127 shares of the industrial products company’s stock after selling 321,944 shares during the period. Los Angeles Capital Management LLC owned 0.18% of Xylem worth $59,016,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. EverSource Wealth Advisors LLC boosted its stake in Xylem by 68.8% in the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 77 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Xylem by 1,185.7% in the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 249 shares in the last quarter. FinTrust Capital Advisors LLC boosted its position in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 200 shares in the last quarter. Hazlett Burt & Watson Inc. grew its stake in Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after buying an additional 220 shares during the last quarter. Finally, UMB Bank n.a. increased its position in Xylem by 96.9% during the 2nd quarter. UMB Bank n.a. now owns 382 shares of the industrial products company’s stock valued at $52,000 after buying an additional 188 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Performance
NYSE XYL traded down $1.32 during mid-day trading on Friday, reaching $126.71. 1,348,183 shares of the stock were exchanged, compared to its average volume of 1,218,682. The company has a market capitalization of $30.78 billion, a P/E ratio of 45.13, a P/E/G ratio of 2.27 and a beta of 1.04. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85. The business’s 50 day moving average is $134.13 and its 200-day moving average is $133.70. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $146.08.
Xylem Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Thursday, August 29th. Xylem’s payout ratio is 51.25%.
Insider Activity
In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of Xylem stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.27% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on XYL shares. Stifel Nicolaus boosted their price target on Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Oppenheimer upped their price target on shares of Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. UBS Group began coverage on shares of Xylem in a research note on Tuesday, August 13th. They set a “buy” rating and a $165.00 price objective for the company. TD Cowen reissued a “hold” rating and issued a $138.00 target price on shares of Xylem in a research report on Tuesday. Finally, Robert W. Baird lifted their price target on Xylem from $155.00 to $170.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 31st. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $147.54.
Read Our Latest Stock Analysis on Xylem
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories
- Five stocks we like better than Xylem
- Manufacturing Stocks Investing
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- 3 Stocks to Consider Buying in October
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- How to Use Stock Screeners to Find Stocks
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.